SOLV News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

SO

Mkt Cap

$14.60B

Volume

666.84K

Next Earnings

November 5th

Loading chart

SO

SOLVSolventum Corporation

SOLV

Pay with—

Available Balance0.00

SO

Mkt Cap

$14.61B

Volume

666.84K

Next Earnings

November 5th

Chart Financials Earnings News About Insider Filings

China Sterilization Equipment Market Outlook to 2033 - Chemical, Physical and Ultraviolet Sterilizers | Revenue, Volume and Pricing Trends Reveal Growth OpportunitiesResearchAndMarkets.com released a comprehensive market report on China's sterilization equipment industry covering chemical, physical, and ultraviolet sterilizers. The report provides revenue, volume, and pricing data from 2018-2033, competitive analysis of major players, and strategic insights for market entry and expansion in this growing sector.GlobeNewswire Inc. · Oct 9, 2026

China Patient Examination Devices Market Size, Share, and Forecast to 2033 - Thermometers and Stethoscopes | Pricing Trends and Growth Opportunities Guide ExpansionA comprehensive market report on China's patient examination devices market covering thermometers and stethoscopes through 2033. The report provides revenue, volume, and pricing data for medical device manufacturers, investors, and healthcare stakeholders, with 2025 company share analysis and competitive intelligence on key market players.GlobeNewswire Inc. · Oct 9, 2026

Can Solventum (SOLV) Keep the Earnings Surprise Streak Alive?Solventum (SOLV), a medical services company, demonstrates a strong track record of beating earnings estimates, with an average surprise of 21.57% over the last two quarters. The company's positive Earnings ESP of +2.81% combined with its Zacks Rank #3 suggests another earnings beat is likely in the near term.Zacks Investment Research · Oct 8, 2026

Why Solventum (SOLV) is a Top Value Stock for the Long-TermSolventum (SOLV), a healthcare company spun off from 3M, is highlighted as a stock to watch with a #3 (Hold) Zacks Rank and a VGM Score of B. The company features attractive valuation metrics with a forward P/E ratio of 11.9 and has seen upward earnings estimate revisions, with an average earnings surprise of +13.2%.Zacks Investment Research · Oct 8, 2026

How to Find Strong Medical Stocks Slated for Positive Earnings SurprisesThe article explains how to identify medical stocks poised for earnings surprises using the Zacks Earnings ESP (Expected Surprise Prediction) tool. It highlights that combining a positive ESP with a Zacks Rank #3 or better has historically produced 70% positive surprises and 28.3% average annual returns. Two medical stocks are featured as examples: Solventum (SOLV) with a +2.81% ESP and ANI Pharmaceuticals (ANIP) with a +6.45% ESP, both expected to report earnings in early November 2026.Zacks Investment Research · Oct 6, 2026

Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical NamesZacks highlights two medical stocks with positive Earnings Surprise Prediction (ESP): CVS Health and Solventum. Both stocks have positive ESP figures and are expected to report earnings in early November 2026, suggesting potential for earnings beats based on recent analyst revisions.Zacks Investment Research · Oct 5, 2026

Why Solventum (SOLV) is a Top Stock for the Long-TermZacks presents its Focus List, a curated portfolio of 50 stocks selected based on positive earnings estimate revisions. The list has historically outperformed the S&P 500, with cumulative returns of 2,519.23% since February 1996 compared to the S&P's 854.95%. The methodology relies on the Zacks Rank system, which evaluates stocks based on earnings consensus among analysts. Solventum (SOLV), a healthcare company spun off from 3M, is highlighted as a recent addition that has gained 29.89% since April 2024.Zacks Investment Research · Sep 15, 2026

Earnings Growth & Price Strength Make Solventum (SOLV) a Stock to WatchSolventum Corporation (SOLV), a healthcare company spun off from 3M, has been added to the Zacks Focus List. The stock has gained 31.53% since its April 2024 IPO at $69.15, now trading at $90.95. Six analysts raised earnings estimates in the last 60 days, with consensus estimates increasing $0.55 to $7.13 for fiscal 2026. The company is expected to deliver 16.7% earnings growth for the current fiscal year and has demonstrated a 13.2% average earnings surprise.Zacks Investment Research · Sep 2, 2026

[Latest] Global Gauze Bandage Rolls Market Size/Share Worth USD 3.19 Billion by 2035 at a 4.97% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)The global gauze bandage rolls market is valued at USD 1.96 billion in 2025 and is projected to reach USD 3.19 billion by 2035, growing at a CAGR of 4.97%. Growth is driven by rising surgical procedures, aging populations, chronic wound management, and technological advancements in antimicrobial and bioactive gauze products. Key market segments include cotton gauze (largest share), surgical wounds (dominant application), and hospitals (primary end-user), with Asia Pacific expected to show the fastest growth.GlobeNewswire Inc. · Jul 3, 2026

3M vs. United Parcel Service: One of These Industrial Stocks Is a Much Better Buy Right Now3M and UPS are both iconic industrial companies facing headwinds, but they present different investment cases. 3M has spun off its healthcare business and faces material legal liabilities from PFAS and military earplugs lawsuits, with valuations above five-year averages despite these risks. UPS is executing a turnaround strategy with upfront costs but showing signs of improvement, trading below five-year valuation averages with a much higher dividend yield. For most investors, particularly dividend seekers, UPS appears the better buy.The Motley Fool · Apr 16, 2026

to start trading

SO

SOLVSolventum Corporation

SOLV

Pay with—

Available Balance0.00

Your PositionYou don't own any SOLV yet.

Related Tickers

Earnings